Advanced search
1 file | 327.24 KB

Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs

(2009) VACCINE. 27(16). p.2258-2264
Author
Organization
Keywords
Pigs, CROSS-REACTIVE IMMUNITY, RESPONSES, ANTIGEN, RECOMBINANT, A H5N1, HONG-KONG, Pox-vector vaccines, PROTECTIVE IMMUNITY, H5N1 avian influenza virus, NUCLEOPROTEIN, HUMANS, TRIAL

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 327.24 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Kyriakis, Konstantinos, Annebel De Vleeschauwer, Filip Barbé, Michel Bublot, and Kristien Van Reeth. 2009. “Safety, Immunogenicity and Efficacy of Poxvirus-based Vector Vaccines Expressing the Haemagglutinin Gene of a Highly Pathogenic H5N1 Avian Influenza Virus in Pigs.” Vaccine 27 (16): 2258–2264.
APA
Kyriakis, K., De Vleeschauwer, A., Barbé, F., Bublot, M., & Van Reeth, K. (2009). Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs. VACCINE, 27(16), 2258–2264.
Vancouver
1.
Kyriakis K, De Vleeschauwer A, Barbé F, Bublot M, Van Reeth K. Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs. VACCINE. 2009;27(16):2258–64.
MLA
Kyriakis, Konstantinos, Annebel De Vleeschauwer, Filip Barbé, et al. “Safety, Immunogenicity and Efficacy of Poxvirus-based Vector Vaccines Expressing the Haemagglutinin Gene of a Highly Pathogenic H5N1 Avian Influenza Virus in Pigs.” VACCINE 27.16 (2009): 2258–2264. Print.
@article{749199,
  author       = {Kyriakis, Konstantinos and De Vleeschauwer, Annebel and Barb{\'e}, Filip and Bublot, Michel and Van Reeth, Kristien},
  issn         = {0264-410X},
  journal      = {VACCINE},
  keyword      = {Pigs,CROSS-REACTIVE IMMUNITY,RESPONSES,ANTIGEN,RECOMBINANT,A H5N1,HONG-KONG,Pox-vector vaccines,PROTECTIVE IMMUNITY,H5N1 avian influenza virus,NUCLEOPROTEIN,HUMANS,TRIAL},
  language     = {eng},
  number       = {16},
  pages        = {2258--2264},
  title        = {Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs},
  url          = {http://dx.doi.org/10.1016/j.vaccine.2009.02.006},
  volume       = {27},
  year         = {2009},
}

Altmetric
View in Altmetric
Web of Science
Times cited: